{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/29/3303734/29517/en/MannKind-Announces-FDA-Approval-of-Afrezza-the-First-and-Only-Inhaled-Mealtime-Insulin-for-Use-in-Children-and-Adolescents-Aged-6-and-Older-Living-with-Diabetes.html", "message": "News view counter 767084 successfully enlarged"}